Overexpression miR-486-3p Promoted by Allicin Enhances Temozolomide Sensitivity in Glioblastoma via Targeting MGMT

NeuroMolecular Medicine - United States
doi 10.1007/s12017-020-08592-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Up-Regulation of miR-370-3p Restores Glioblastoma Multiforme Sensitivity to Temozolomide by Influencing MGMT Expression

Scientific Reports
Multidisciplinary
2016English

miR-342-3p Promotes Osteogenic Differentiation via Targeting ATF3

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2018English

JNK Contributes to Temozolomide Resistance of Stem-Like Glioblastoma Cells via Regulation of MGMT Expression

International Journal of Oncology
Cancer ResearchOncology
2013English

A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

MiR-490-3p Inhibits Autophagy via Targeting ATG7 in Hepatocellular Carcinoma

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

miR-519a Enhances Chemosensitivity and Promotes Autophagy in Glioblastoma by Targeting STAT3/Bcl2 Signaling Pathway

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1

OncoTargets and Therapy
OncologyPharmacology
2019English

Sulforaphane Reverses Chemo-Resistance to Temozolomide in Glioblastoma Cells by NF-κB-dependent Pathway Downregulating MGMT Expression

International Journal of Oncology
Cancer ResearchOncology
2015English

Metabolic Targeting of EGFRvIII/PDK1 Axis in Temozolomide Resistant Glioblastoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy